TY - JOUR
T1 - Cellular kinetics in rectal cancer
AU - Terry, N. H.A.
AU - Meistrich, M. L.
AU - Roubein, L. D.
AU - Lynch, P. M.
AU - Dubrow, R. A.
AU - Rich, T. A.
N1 - Funding Information:
Pearce for clinical data acquisition, Maria Rodionov for assistance in measuring tumour volumes, and Dr R Allen White for his construc-tive criticism. The study was supported by NIH/NCI Grant CA-
PY - 1995/8
Y1 - 1995/8
N2 - Measurements of dynamic tumour cell kinetic parameters, particularly the potential doubling time (Tpot) may have potential as predictive assays for treatment outcome after radiotherapy. This paper details the distributions of Tpot and other kinetic and DNA content parameters measured in rectal cancers. Biopsies were taken from 119 patients approximately 6 h after infusion of 200 mg m-2 bromodeoxyuridine (BrdUrd). The samples were analysed by bivariate DNA/BrdUrd flow cytometry. The primary purpose of the study was to measure the kinetic parameters of labelling index (LI), duration of S-phase (TS) and Tpot. Secondarily, tumour DNA ploidy (DNA index) and S-phase fractions (SPFs) were also estimated from the univariate DNA histograms. The 101 evaluable patients were classified according to clinical stage as T2 (n = 12), T3 (n = 53), T4 (n = 28) or recurrent tumours (n = 8). Of the evaluable tumours, 73 were DNA aneuploid. The median LI, TS, and Tpot of the aneuploid tumours were 21%, 20 h and 3.3 days respectively. The calculated LI, TS, and Tpot of diploid tumours were subject to uncertainties because of the contribution of normal cells. The LI and SPF of all tumours were, however, significantly (P #x2038; 0.001) correlated, having a correlation coefficient of only 0.76. The wide distributions of values for LI (quartiles 13.5%, 26.9%) and Tpot (quartiles 2.4, 5.6 days) that were found are necessary baseline information if these parameters are to be useful in individual treatment selection or as predictors of treatment outcome.
AB - Measurements of dynamic tumour cell kinetic parameters, particularly the potential doubling time (Tpot) may have potential as predictive assays for treatment outcome after radiotherapy. This paper details the distributions of Tpot and other kinetic and DNA content parameters measured in rectal cancers. Biopsies were taken from 119 patients approximately 6 h after infusion of 200 mg m-2 bromodeoxyuridine (BrdUrd). The samples were analysed by bivariate DNA/BrdUrd flow cytometry. The primary purpose of the study was to measure the kinetic parameters of labelling index (LI), duration of S-phase (TS) and Tpot. Secondarily, tumour DNA ploidy (DNA index) and S-phase fractions (SPFs) were also estimated from the univariate DNA histograms. The 101 evaluable patients were classified according to clinical stage as T2 (n = 12), T3 (n = 53), T4 (n = 28) or recurrent tumours (n = 8). Of the evaluable tumours, 73 were DNA aneuploid. The median LI, TS, and Tpot of the aneuploid tumours were 21%, 20 h and 3.3 days respectively. The calculated LI, TS, and Tpot of diploid tumours were subject to uncertainties because of the contribution of normal cells. The LI and SPF of all tumours were, however, significantly (P #x2038; 0.001) correlated, having a correlation coefficient of only 0.76. The wide distributions of values for LI (quartiles 13.5%, 26.9%) and Tpot (quartiles 2.4, 5.6 days) that were found are necessary baseline information if these parameters are to be useful in individual treatment selection or as predictors of treatment outcome.
KW - Bromodeoxyuridine labelling index
KW - Flow cytometry
KW - Potential doubling time
KW - Predictive assays
KW - Rectal cancer
KW - Tumour cell kinetics
UR - http://www.scopus.com/inward/record.url?scp=0029127971&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029127971&partnerID=8YFLogxK
U2 - 10.1038/bjc.1995.351
DO - 10.1038/bjc.1995.351
M3 - Article
C2 - 7640229
AN - SCOPUS:0029127971
SN - 0007-0920
VL - 72
SP - 435
EP - 441
JO - British journal of cancer
JF - British journal of cancer
IS - 2
ER -